What is Reata Pharmaceuticals, Inc.'s official website?

Reata Pharmaceuticals, Inc.'s website is reatapharma.com

How many employees are working in Reata Pharmaceuticals, Inc. right now?

Reata Pharmaceuticals, Inc. has 99 employees.

What is Reata Pharmaceuticals, Inc.'s industry?

Reata Pharmaceuticals, Inc.'s industry is Pharmaceutical Manufacturing

Who are Reata Pharmaceuticals, Inc.'s top competitors?

Reata Pharmaceuticals, Inc.'s top competitors are , , , , , ,

Reata Pharmaceuticals, Inc. company information, Employees & Contact Information

Explore related pages

Reata Pharmaceuticals, Inc. email format Reata Pharmaceuticals, Inc. management contacts

Related company profiles:

Reata Pharmaceuticals has been acquired by Biogen. Please follow along there for the latest news. This page is no longer updated or monitored.

Employees: 99
Founded: -
Address: 5320 Legacy Dr, Bldg 2,united States
Phone: 972-865-2219
Email: in****@****rma.com
Industry: Pharmaceutical Manufacturing
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

In-Vitro Diagnostic Substance Manufacturing

Biological Product (except Diagnostic) Manufacturing
Website: reatapharma.com
Keywords: Biopharmaceuticals, Research, Clinical Operations, Biotechnology.
HQ: Plano, Texas
Competitors: Biogen, Alnylam Pharmaceuticals, Lexicon Pharmaceuticals, Inc., Aurinia Pharmaceuticals Inc., Crinetics Pharmaceuticals, TerSera Therapeutics, Agios Pharmaceuticals, Summit Therapeutics, Inc., Pfizer, Vertex Pharmaceuticals.

Reata Pharmaceuticals, Inc. Questions

News

Biogen to Acquire Reata Pharmaceuticals - Biogen

Biogen to Acquire Reata Pharmaceuticals Biogen

Reata Pharmaceuticals, Inc. Announces First Quarter 2023 Financial Results and Provides an Update on Operational Progress and Clinical Development Programs - Business Wire

Reata Pharmaceuticals, Inc. Announces First Quarter 2023 Financial Results and Provides an Update on Operational Progress and Clinical Development Programs Business Wire

Bardoxolone Gets Orphan Drug Status for Autosomal Dominant Polycystic Kidney Disease - Renal and Urology News

Bardoxolone Gets Orphan Drug Status for Autosomal Dominant Polycystic Kidney Disease Renal and Urology News

Reata Announces Positive Topline Results from the MOXIe - GlobeNewswire

Reata Announces Positive Topline Results from the MOXIe GlobeNewswire

Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreich’s Ataxia - Business Wire

Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreich’s Ataxia Business Wire

New Study Tests Lotion To Treat Radiation Dermatitis in Breast Cancer Patients - radiationtherapynews.com

New Study Tests Lotion To Treat Radiation Dermatitis in Breast Cancer Patients radiationtherapynews.com

Reata Announces FDA Accepted for Filing the NDA for - GlobeNewswire

Reata Announces FDA Accepted for Filing the NDA for GlobeNewswire

Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omavaloxolone), the First and Only Drug Indicated for Patients with Friedreich’s Ataxia - Business Wire

Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omavaloxolone), the First and Only Drug Indicated for Patients with Friedreich’s Ataxia Business Wire

Reata Pharmaceuticals Reacquires Rights From AbbVie to - GlobeNewswire

Reata Pharmaceuticals Reacquires Rights From AbbVie to GlobeNewswire

(Omaveloxolone) and Commercial Availability of SKYCLARYS for Patients with Friedreich’s Ataxia - Business Wire

(Omaveloxolone) and Commercial Availability of SKYCLARYS for Patients with Friedreich’s Ataxia Business Wire

Companies like Reata Pharmaceuticals, Inc.

Top Reata Pharmaceuticals, Inc. Employees

Julie Fazio

Independent Clinical Research Consultant

Greater Cleveland, United States

View

1
gmail.com
James Rouse

n/a

Irving, Texas, United States, United States

View

4
ptcbio.com, covance.com, reatapharma.com, reatapharma.com

1 +197257XXXXX
Marnie Romer

n/a

Cincinnati, Ohio, United States, United States

View

3
sbcglobal.net, yahoo.com, sbcglobal.net

2 +151375XXXXX
Warren Huff

n/a

Dallas, Texas, United States, United States

View

2
reatapharma.com, reatapharma.com

1 +197257XXXXX

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Reata Pharmaceuticals, Inc. company information, Employees & Contact Information

Explore related pages

Company Details

Reata Pharmaceuticals, Inc. Questions

What is Reata Pharmaceuticals, Inc.'s helpline number?

What is Reata Pharmaceuticals, Inc.'s official website?

What is Reata Pharmaceuticals, Inc.'s LinkedIn profile?

How many employees are working in Reata Pharmaceuticals, Inc. right now?

What is Reata Pharmaceuticals, Inc.'s industry?

What are Reata Pharmaceuticals, Inc.'s top competitors?

What is Reata Pharmaceuticals, Inc.'s support email address?

What are Reata Pharmaceuticals, Inc.'s categories?

When was Reata Pharmaceuticals, Inc. founded?

News

Biogen to Acquire Reata Pharmaceuticals - Biogen

Reata Pharmaceuticals, Inc. Announces First Quarter 2023 Financial Results and Provides an Update on Operational Progress and Clinical Development Programs - Business Wire

Bardoxolone Gets Orphan Drug Status for Autosomal Dominant Polycystic Kidney Disease - Renal and Urology News

Reata Announces Positive Topline Results from the MOXIe - GlobeNewswire

Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreich’s Ataxia - Business Wire

New Study Tests Lotion To Treat Radiation Dermatitis in Breast Cancer Patients - radiationtherapynews.com

Reata Announces FDA Accepted for Filing the NDA for - GlobeNewswire

Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omavaloxolone), the First and Only Drug Indicated for Patients with Friedreich’s Ataxia - Business Wire

Reata Pharmaceuticals Reacquires Rights From AbbVie to - GlobeNewswire

(Omaveloxolone) and Commercial Availability of SKYCLARYS for Patients with Friedreich’s Ataxia - Business Wire

Companies like Reata Pharmaceuticals, Inc.

Summit Therapeutics,...

Vertex Pharmaceuticals

Lexicon Pharmaceutic...

Biogen

Pfizer

Tersera Therapeutics

Aurinia Pharmaceutic...

Crinetics Pharmaceut...

Alnylam Pharmaceuticals

Agios Pharmaceuticals

Top Reata Pharmaceuticals, Inc. Employees

Julie Fazio

Independent Clinical Research Consultant

James Rouse

n/a

Marnie Romer

n/a

Warren Huff

n/a

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data